LUMAKRAS™ (Sotorasib) Combined With Vectibix® (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer

September 16, 2021
8:30 am

LUMAKRAS™ (Sotorasib) Combined With Vectibix® (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer

New Data at ESMO 2021 Support Initiation of Phase 3 Trial of LUMAKRAS Plus Vectibix in Patients With 3L+ Colorectal Cancer
Amgen is Leading the Largest and Most Comprehensive Development Program in Patients with the KRAS G12C Mutation
THOUSAND OAKS, Calif.,…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

Circle Internet, crypto miners report earnings: Crypto Week Ahead

February 23, 2026

Jack Dorsey’s Block Gears For Q4 Earnings: Analyst Expectations, Key Technical Signals, Price Targets And All You Need To Know – Block (NYSE:XYZ)

February 23, 2026

Is Bitdeer Technologies Group (BTDR) Pricing Reflect Recent Share Slide And Crypto Infrastructure Focus

February 23, 2026

Should You Hold or Fold the Stock? — TradingView News

February 23, 2026

Bitcoin falls below $65K as tariff tensions weigh on crypto

February 23, 2026

Will Coinbase Crash or Rally in Feb 2026?

February 23, 2026

Crypto exchange BTCC adds TradFi CFDs

February 23, 2026

(RS) Stock Market Analysis

February 23, 2026